Clinical uses and misuses of dehydroepiandrosterone

Curr Opin Pharmacol. 2003 Dec;3(6):635-41. doi: 10.1016/j.coph.2003.07.006.

Abstract

Dehydroepiandrosterone is the most abundant adrenal androgen and also functions as a neurosteroid. Serum concentrations decline with age and can serve as a prognostic factor in both critical illnesses and breast cancer progression. Evidence is accruing in support of dehydroepiandrosterone supplementation in adrenal insufficiency, hypopituitarism, osteoporosis, systemic lupus erythematosus, depression and schizophrenia. Research is ongoing at both the basic and the clinical level to elucidate mechanisms of action and establish efficacy and safety, as well as to expand new areas of potential application for this multi-faceted hormone.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Adjuvants, Immunologic / pharmacology
  • Adjuvants, Immunologic / therapeutic use
  • Autoimmune Diseases / drug therapy
  • Autoimmune Diseases / immunology
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / metabolism
  • Clinical Trials as Topic
  • Dehydroepiandrosterone / metabolism
  • Dehydroepiandrosterone / pharmacology
  • Dehydroepiandrosterone / therapeutic use*
  • Endocrine System Diseases / drug therapy
  • Endocrine System Diseases / physiopathology
  • Humans
  • Neoplasms / drug therapy
  • Nervous System Diseases / drug therapy

Substances

  • Adjuvants, Immunologic
  • Dehydroepiandrosterone